Effects of febuxostat and allopurinol on the inflammation and cardiac function in chronic heart failure patients with hyperuricemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of febuxostat and allopurinol on the inflammation and cardiac function in chronic heart failure patients with hyperuricemia

Published:2015-09 Issue: Volume:8 Page:46-55
ISSN:2214-7624
Container-title:IJC Metabolic & Endocrine
language:en
Short-container-title:IJC Metabolic & Endocrine

Author:

Nakagomi Akihiro,Saiki Yoshiyuki,Noma Satsuki,Kohashi Keiichi,Morisawa Taichirou,Kosugi Munenori,Kusama Yoshiki,Atarashi Hirotsugu,Shimizu Wataru

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Reference48 articles.

1. Uric acid and risk of heart failure: a systemic review and meta-analysis;Huang;Eur. J. Heart Fail.,2014

2. Hyperuricemia and incident heart failure;Krishnan;Circ. Heart Fail.,2009

3. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study;Ekundayo;Int. J. Cardiol.,2010

4. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging;Anker;Circulation,2003

5. Cytokines and myocardial dysfunction: state of the art;El-Menyar;J. Card. Fail.,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta‐analysis;Clinical and Translational Science;2024-03

2. Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia;JCR: Journal of Clinical Rheumatology;2023-12-20

3. Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials;BMC Pharmacology and Toxicology;2023-12-14

4. Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Cardiovascular Development and Disease;2023-09-04

5. Update in uric acid, hypertension, and cardiovascular diseases;Hypertension Research;2023-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3